Simcere Pharmaceutical Group



Quote for Simcere Pharmaceutical Group

Last Trade:
-
Change:
--
Symbol:
SCR
Status:
-
Listed In:
NYSE
P/E:
-
EPS:
-
Market cap:
-
Beta:
-
Open:
-
Prev Close:
-
Capital:
-
Volume:
-
Average vol:
-
Amount:
-
Day's Range:
-
52 week Range:
-
Update:-
Quote Delayed 15 Min.
Currency in USD Time=EDTSCR quote

Summary for Simcere Pharmaceutical Group

Simcere Pharmaceutical Group is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. The Company has introduced a generic anti-stroke medication under the brand name Bicun, a 5-FU sustained release implant under the brand name Sinofuan, Anxin, Jiebaishu and an anti-cancer medication under the brand name Endu. As of December 31,2010, the Company manufactures and sells 51 principal pharmaceutical products and are the exclusive distributor of two additional pharmaceuticals that are manufactured by independent third parties but marketed under its brand names. As of March 31, 2011, it also had over 13 product candidates in various stages of development, including treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea and vomiting associated with chemotherapy. During the year ended December 31, 2010, it completed the acquisition of an additional 39.2% stake in Jilin Boda.